Search - tctmd.com

Displaying 521 - 536 of 536

Sort: Relevancy | Date

News Daily News

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

L.A. McKeown

August 01, 2012

News Daily News

El Pantoprazol No es Necesariamente un PPI Seguro para Pacientes a Tratamiento con Terapia Antiplaquetaria Doble

L.A. McKeown

August 01, 2012

News Daily News

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Caitlin E. Cox

March 07, 2012

News Daily News

Six Months Sufficient for Dual Antiplatelet Therapy

Jason Kahn

October 17, 2011

News Conference News

Long-term Antiplatelet Therapy: All Risk, No Benefit

August 30, 2011

News Daily News

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

July 27, 2011

News Daily News

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

July 20, 2011

News Daily News

Adding Omega-3 Fatty Acids to Dual Antiplatelet Therapy May Reduce Thrombotic Risk

Leah Lawrence

May 26, 2011

News Daily News

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

Caitlin E. Cox

May 10, 2011

News Conference News

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

Caitlin E. Cox

April 05, 2011

News Daily News

Aspirin’s GI Bleeding Risk Increased by Concomitant Use of Gastrotoxic Drugs

Caitlin E. Cox

March 10, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Daily News

Late Aspirin Use Before CABG Does Not Increase Ischemic Events

Jason Kahn

February 02, 2011

News Daily News

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

January 09, 2011

News Daily News

Dabigatran an Alternative to Warfarin for Stroke Prevention in A-Fib Patients

Kim Dalton

September 03, 2009

CME

Advertisement

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

El Pantoprazol No es Necesariamente un PPI Seguro para Pacientes a Tratamiento con Terapia Antiplaquetaria Doble

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Six Months Sufficient for Dual Antiplatelet Therapy

Long-term Antiplatelet Therapy: All Risk, No Benefit

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

Adding Omega-3 Fatty Acids to Dual Antiplatelet Therapy May Reduce Thrombotic Risk

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

Aspirin’s GI Bleeding Risk Increased by Concomitant Use of Gastrotoxic Drugs

Cilostazol Reduces Repeat Revascularizations for Long Lesions

Late Aspirin Use Before CABG Does Not Increase Ischemic Events

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

Dabigatran an Alternative to Warfarin for Stroke Prevention in A-Fib Patients

Optimizing the Duration of DAPT following PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content